Clearmind Medicine (CMND) Change in Acquisitions & Divestments (2022 - 2025)
Clearmind Medicine (CMND) posted quarterly Change in Acquisitions & Divestments of -$514591.0 for Q4 2025, down 19.98% year-over-year from -$643071.9 in Q4 2024, and down 81.86% quarter-over-quarter from -$282960.0 in Q2 2025.
Clearmind Medicine (CMND) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
Clearmind Medicine's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at -$514591.0 for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments fell 19.98% year-over-year to -$514591.0; the TTM figure through Oct 2025 stood at -$714591.0 (changed N/A YoY), while the FY2025 annual figure was -$714591.0, down 103.94% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at -$514591.0, down from -$282960.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $455.5 billion in Q3 2022, with the low at -$514591.0 in Q4 2025.
- The 3-year median for Change in Acquisitions & Divestments is -$282960.0 (2025), against an average of $91.1 billion.
- Peak annual rise in Change in Acquisitions & Divestments reached 19.98% in 2025, while the deepest fall reached 19.98% in 2025.
- Clearmind Medicine's Change in Acquisitions & Divestments stood at $455.5 billion in 2022, then plunged by 100.0% to -$428900.0 in 2024, then declined by 19.98% to -$514591.0 in 2025.
- Business Quant data shows CMND's Change in Acquisitions & Divestments at -$514591.0 in Q4 2025, -$282960.0 in Q2 2025, and $82960.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -514,591.00 |
| Oct 31, 2025 | -514,591.00 |
| Apr 30, 2025 | -282,960.00 |
| Apr 30, 2025 | -282,960.00 |
| Jan 31, 2025 | 82,960.00 |
| Jan 31, 2025 | 82,960.00 |
| Oct 31, 2024 | -428,900.00 |
| Oct 31, 2024 | -428,900.00 |
| Jul 31, 2022 | 455.49 Bn |
| Jul 31, 2022 | 455.49 Bn |